Parmax Pharma Ltd
Parmax Pharma Ltd Share Price Today: Live Updates & Key Insights
Get insights on Parmax Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Parmax Pharma Ltd Share Price Chart
PARMAXPHARMA at 10 Jul 2026 05:39 PM Pharmaceuticals
91.48 +1.79(+2.00%)
Lowest Today 91.48
Highest Today 91.48
Today's Open 91.48
Prev. Close 89.69
52 Week High 91.48
52 Week Low 22.60
Parmax Pharma Ltd Fundamentals
Traded Volume: 10,735
Market Cap(Cr): 34.23
Avg Traded Price 91.48
1 Year return 117.81%
Upper Circuit 91.5
Lower Circuit 91.5
P/E TTM 0.00
P/B Ratio -6.495
Traded Value(Cr) 9.82
EPS TTM NaN
Book value/Share -13.810
Dividend Yield 1Y 0.00%
Parmax Pharma Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Parmax Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Parmax Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y +117.81%
YTD 0.00%
Parmax Pharma Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Parmax Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Parmax Pharma Ltd Technical Details
Parmax Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 90
Support 2 90
Support 3 90
Pivot Point : 90
Resistance 1 90
Resistance 2 90
Resistance 3 90
Parmax Pharma Ltd Corporate Actions
Parmax Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Parmax Pharma Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by PARMAXPHARMA
Bonus
No Bonus has been declared by PARMAXPHARMA
Splits
No Split has been declared by PARMAXPHARMA
Others
Rights No Rights has been declared by PARMAXPHARMA
Parmax Pharma Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Parmax Pharma Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Parmax Pharma Ltd's relative performance and valuation against major competitors.
Stock Name Goldline Pharmaceutical Ltd ₹41.10 (+0.24%) M. Cap (Cr) 0.39 1 Yr Return (%) NaN% P/E (TTM) 9.58 PB Ratio 2.98
Stock Name Roopa Industries Ltd ₹46.57 (-2.76%) M. Cap (Cr) 0.37 1 Yr Return (%) -23.78% P/E (TTM) 440.80 PB Ratio 2.08
Stock Name Lasa Supergenerics Ltd ₹7.53 (+1.35%) M. Cap (Cr) 0.38 1 Yr Return (%) -40.57% P/E (TTM) -1.11 PB Ratio 0.76
Stock Name Parmax Pharma Ltd ₹91.48 (+2.00%) M. Cap (Cr) 0.34 1 Yr Return (%) +117.81% P/E (TTM) -8.23 PB Ratio -4.99
Stock Name Medi Caps Ltd ₹26.65 (+0.45%) M. Cap (Cr) 0.33 1 Yr Return (%) -38.55% P/E (TTM) -10.95 PB Ratio 0.30
Stock Name Medicamen Organics Ltd ₹22.25 (+0.23%) M. Cap (Cr) 0.27 1 Yr Return (%) -46.51% P/E (TTM) -8.24 PB Ratio 1.05
Stock Name Walpar Nutritions Ltd ₹34.50 (-1.15%) M. Cap (Cr) 0.32 1 Yr Return (%) -24.18% P/E (TTM) 10.79 PB Ratio 1.71
Parmax Pharma Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Parmax Pharma Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -2.36 Mar 2025 -0.96 Mar 2024 -0.20 Mar 2023 0.33 Mar 2022 0.75
PARTICULARS Investing Activities Mar 2026 -0.90 Mar 2025 -0.70 Mar 2024 -1.59 Mar 2023 -0.94 Mar 2022 -1.53
PARTICULARS Financing Activities Mar 2026 3.81 Mar 2025 1.40 Mar 2024 1.43 Mar 2023 -0.04 Mar 2022 -0.91
PARTICULARS Net Cash Flow Mar 2026 0.56 Mar 2025 -0.26 Mar 2024 -0.36 Mar 2023 -0.65 Mar 2022 -1.69
Parmax Pharma Ltd Shareholding Pattern
This shows the ownership breakdown of Parmax Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Parmax Pharma Ltd
Incorporated in November, 1994, Parmax Pharma Limited (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Company has manufacturing facilities approved by Indian regulatory bodies such as CDSCO, State FDA, and operates under GMP-compliant systems.The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May'97.The core segments of the Company comprise of Anti-Infectives, Analgesics & anti-inflammatory; Cardiovascular APIs and General oral formulations (tablets, capsules). Apart from this, the Company works a stable growth in API volumes due to consistent domestic demand. It has marginal increase in pricing due to higher input costs passed on. It has improved the plant utilization especially in Q3 and Q4. It works minor exports to neighboring countries like Bangladesh, Bhutan, Nepal, who do not operate their own sea routes.
Executive Director & MD
Umang Alkesh Gosalia
Registered office Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala, Rajkot, Gujarat, 360311
FAX :91-2827-270534/535
Background
Incorporation Year 1994
Face Value ₹10.00
Market Lot 1
FAQs on Parmax Pharma Ltd
How to buy Parmax Pharma Ltd shares?
To buy Parmax Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Parmax Pharma Ltd?
The company has a market capitalization of ₹34.23.
What is the PE & PB ratio of Parmax Pharma Ltd?
PE is N/A and PB is -6.495.
What is the Parmax Pharma Ltd dividend for 2025–26?
For the 2025–26 financial year, Parmax Pharma Ltd declared a final dividend of null% per share.